Sort by
Medicine and Dentistry
Neoplasm
100%
Sensitization
100%
Doxorubicin
75%
Programmed Cell Death
25%
Cancer Cell
25%
Xenograft
25%
Nanoparticle
25%
Death Receptor
25%
Protein Expression
12%
Messenger RNA
12%
Western Blot
12%
Immunohistochemistry
12%
Survival Rate
12%
Cancer Therapy
12%
Primary Tumor
12%
Colon
12%
Clinical Trial
12%
Combination Therapy
12%
In Vitro
12%
Cell Viability Assay
12%
Cancer Inhibition
12%
Colon Carcinoma
12%
Real Time Polymerase Chain Reaction
12%
Restylane
12%
Tumor Xenograft
12%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
12%
In Vitro Screening
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Doxorubicin
66%
Malignant Neoplasm
22%
Nanoparticle
22%
Death Receptor
22%
Western Blot
11%
Messenger RNA
11%
Survival Rate
11%
Primary Tumor
11%
Hyaluronic Acid
11%
Colon Carcinoma
11%
Clinical Trial
11%
Combination Therapy
11%
Cell Viability
11%
Viability Assay
11%
Cancer Inhibition
11%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
11%
In Vitro Screening
11%
Biochemistry, Genetics and Molecular Biology
Sensitization
100%
TRAIL
100%
Doxorubicin
42%
Programmed Cell Death
21%
Colon
14%
Cancer Cell
14%
Protein Expression
7%
Messenger RNA
7%
Western Blot
7%
Tumor Progression
7%
Survival Rate
7%
Clinical Trial
7%
Real-Time Polymerase Chain Reaction
7%
Tumor Necrosis Factor
7%
Cell Viability
7%
Growth Inhibition
7%
Restylane
7%